                         SEQUENCE LISTING

<110>  Lawrence Livermore National Security, LLC
       Coleman, Matthew  A.
       Hoeprich, Paul D.
       Arroyo, Erin S.
       Cappuccio, Jenny A.
 
<120>  Methods and Systems for Monitoring Production of a Target Protein
        in a Nanolipoprotein Particle

<130>  P196-PCT

<140>  To be assigned
<141>  2008-05-09

<150>  60/928,579
<151>  2007-05-09

<150>  60/928,573
<151>  2007-05-09

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligonucleotide

<400>  1
atgctaaagc tccttgacaa ctgg                                              24


<210>  2
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligonucleotide

<400>  2
ttactgggtg ttgagcttct tagtg                                             25


<210>  3
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligonucleotide

<400>  3
ggggcatatg caagctcaaa t                                                 21


<210>  4
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligonucleotide

<400>  4
ggggatccaa aaaaaacggg cc                                                22


<210>  5
<211>  193
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  22 kD Apolipoprotein E4 construct

<400>  5

Gly Ser Lys Val Glu Gln Ala Val Glu Thr Glu Pro Glu Pro Glu Leu 
1               5                   10                  15      


Arg Gln Gln Thr Glu Trp Gln Ser Gly Gln Arg Trp Glu Leu Ala Leu 
            20                  25                  30          


Gly Arg Phe Trp Asp Tyr Leu Arg Trp Val Gln Thr Leu Ser Glu Gln 
        35                  40                  45              


Val Gln Glu Glu Leu Leu Ser Ser Gln Val Thr Gln Glu Leu Arg Ala 
    50                  55                  60                  


Leu Met Asp Glu Thr Met Lys Glu Leu Lys Ala Tyr Lys Ser Glu Leu 
65                  70                  75                  80  


Glu Glu Gln Leu Thr Pro Val Ala Glu Glu Thr Arg Ala Arg Leu Ser 
                85                  90                  95      


Lys Glu Leu Gln Ala Ala Gln Ala Arg Leu Gly Ala Asp Met Glu Asp 
            100                 105                 110         


Val Arg Gly Arg Leu Val Gln Tyr Arg Gly Glu Val Gln Ala Met Leu 
        115                 120                 125             


Gly Gln Ser Thr Glu Glu Leu Arg Val Arg Leu Ala Ser His Leu Arg 
    130                 135                 140                 


Lys Leu Arg Lys Arg Leu Leu Arg Asp Ala Asp Asp Leu Gln Lys Arg 
145                 150                 155                 160 


Leu Ala Val Tyr Gln Ala Gly Ala Arg Glu Gly Ala Glu Arg Gly Leu 
                165                 170                 175     


Ser Ala Ile Arg Glu Arg Leu Gly Pro Leu Val Glu Gln Gly Arg Val 
            180                 185                 190         


Arg 
    


